4.5 Article

Targeting the autophagy pathway for cancer chemoprevention

Journal

CURRENT OPINION IN CELL BIOLOGY
Volume 22, Issue 2, Pages 218-225

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2009.12.013

Keywords

-

Categories

Funding

  1. NRSA [5F32 CA123777-03]
  2. Lehman Brothers Foundation
  3. State of Florida
  4. NATIONAL CANCER INSTITUTE [F32CA123777] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Autophagy is crucial for maintaining cellular homeostasis, coping with metabolic stress, and limiting oxidative damage. Several autophagy-deficient or knockout models show increased tumor incidence, implicating autophagy as a tumor suppressor. Autophagy is involved in multiple processes that may curb transformation, including the control of oncogene-induced senescence (OIS), which can limit progression to full malignancy, and efficient antigen presentation, which is crucial for immune cell recognition and elimination of nascent cancer cells. Activation of the autophagy pathway may therefore hold promise as a chemoprevention strategy. Caloric restriction, bioactive dietary compounds, or specific pharmacological activators of the autophagy pathway are all possible avenues to explore in harnessing the autophagy pathway in cancer prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available